Optomed Oyj - Other information disclosed according to the rules of the Exchange

No updates on the Optomed Aurora AEYE FDA clearance process

Optomed PlcStock Exchange Release29 April 2024 at 13:20, Helsinki

No updates on the Optomed Aurora AEYE FDA clearance process

Optomed is together with its partner AEYE Health in the process of obtaining a
clearance for the AI fundus camera Optomed Aurora AEYE.

At this stage, Optomed does not have any new information regarding the FDA
clearance process. Optomed will update market as new information becomes
available.

Optomed Plc

Further enquiries

Juho Himberg, CEO, juho.himberg@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and a leading manufacturer of
handheld fundus cameras and screening software. Optomed combines handheld fundus
cameras with software and artificial intelligence with the aim to transform the
diagnostic process of various diseases, such as rapidly increasing diabetic
retinopathy. Optomed has offices in Finland, the US and China and the company's
products are sold via various sales channels in over 60 countries globally

www.optomed.com